NYMC Faculty Publications
DOI
10.21037/jtd.2018.05.24
Journal Title
Journal of Thoracic Disease
First Page
2866
Last Page
2875
Document Type
Article
Publication Date
5-1-2018
Department
Surgery
Abstract
Background: Elevated systemic blood pressure (SBP) has been linked to complications in Continuous-flow left ventricular assist devices (CF-LVADs), including stroke and pump thrombosis. We queried Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) to describe the response of SBP to CF-LVAD implantation and to delineate contemporary trends in antihypertensive (AH) utilization for patients with these pumps. Methods: We identified all CF-LVAD implantations in patients older than 18 years from 2006-2014, excluding those whose durations were less than 30 days. Pre-implant patient demographics and characteristics were obtained for each record. SBPs [i.e., mean arterial pressures (MAPs)], AH-use data, and vital status were tabulated, extending up to 5 years following implantation. Results: A total of 10,329 CF-LVAD implantations were included for study. Post-implant, SBPs increased rapidly during the first 3 months but plateaued thereafter; AH utilization mirrored this trend. By 6 months, mean MAPs climbed 12.2% from 77.6 mmHg (95% CI: 77.4-77.8) pre-implantation to 87.1 mmHg (95% CI: 86.7-87.4) and patients required a mean of 1.8 AH medications (95% CI: 1.75-1.78) -a 125% increase from AH use at 1-week post-implantation (0.8 AHs/patient, 95% CI: 0.81-0.83) but a 5.3% decrease from pre-implant utilization (1.9 AHs/patient, 95% CI: 1.90-1.92). Once medication changes stabilized, the most common AH regimens were lone beta blockade (15%, n=720) and a beta blocker plus an ACE inhibitor (14%, n=672). Conclusions: SBP rises rapidly after CF-LVAD implantation, stabilizing after 3 months, and is matched by concomitant changes in AH utilization; this AH use has increased over consecutive implant years.
Recommended Citation
Elmously, A., de Biasi, A., Risucci, D., Worku, B., Horn, E., & Salemi, A. (2018). Systemic Blood Pressure Trends and Antihypertensive Utilization Following Continuous-Flow Left Ventricular Assist Device Implantation: an Analysis of the Interagency Registry for Mechanically Assisted Circulatory Support. Journal of Thoracic Disease, 10 (5), 2866-2875. https://doi.org/10.21037/jtd.2018.05.24
Publisher's Statement
Originally published in Journal of Thoracic Disease, 10(5), 2866-2875. The original material can be found here.
Included in
Cardiology Commons, Other Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons, Therapeutics Commons
